Key points from article :
Researchers from University of Cambridge cdeveloped an experimental vaccine in mice that could potentially protect against a wide variety of coronaviruses, including those not yet discovered.
The vaccine works by training the immune system to recognize common proteins found in different coronaviruses, using harmless proteins attached to tiny nanoparticles.
This approach, called "proactive vaccinology," aims to design vaccines before a potential pandemic virus emerges.
Tests showed the vaccine induced a broad immune response, even protecting against the SARS-CoV-1 virus, despite its proteins not being included in the vaccine.
The vaccine can be produced using existing manufacturing methods and researchers are working on scaling up production.
While not yet approved for humans, researchers suggest the vaccine could be stockpiled and used as a booster against future coronavirus outbreaks.
The study is published in the journal Nature Nanotechnology.
